FDA Recall D-0179-2026
Medical Products Laboratories, Inc. · Philadelphia, PA
Class II Ongoing 183 days on record
Moderate impact — Class II recall โ temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.
Product
Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01
Reason for recall
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Recall record
- Recall number
D-0179-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- Nationwide USA
- Recall initiated
- 2025-11-12
- Classified by FDA Center
- 2025-11-21
- FDA published
- 2025-12-03
- Recalling firm
- Medical Products Laboratories, Inc.
- Firm location
- Philadelphia, PA
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.